APA (7th ed.) Citation

I, A., CD, R., E, d. S., G, C., C, C., SW, L., & CJ, S. (2015). Janus kinase inhibition by ruxolitinib extends dasatinib- and dexamethasone-induced remissions in a mouse model of Ph+ ALL. Blood, 125(9), 1444. https://doi.org/10.1182/blood-2014-09-601062

Chicago Style (17th ed.) Citation

I, Appelmann, Rillahan CD, de Stanchina E, Carbonetti G, Chen C, Lowe SW, and Sherr CJ. "Janus Kinase Inhibition by Ruxolitinib Extends Dasatinib- and Dexamethasone-induced Remissions in a Mouse Model of Ph+ ALL." Blood 125, no. 9 (2015): 1444. https://doi.org/10.1182/blood-2014-09-601062.

MLA (9th ed.) Citation

I, Appelmann, et al. "Janus Kinase Inhibition by Ruxolitinib Extends Dasatinib- and Dexamethasone-induced Remissions in a Mouse Model of Ph+ ALL." Blood, vol. 125, no. 9, 2015, p. 1444, https://doi.org/10.1182/blood-2014-09-601062.